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Abstract
Background: For decades, research efforts have tried to uncover the underlying genetic basis of human susceptibility to a
variety of diseases. Linkage studies have resulted in highly replicated findings and helped identify quantitative trait loci
(QTL) for many complex traits; however identification of specific alleles accounting for linkage remains elusive. The purpose
of this study was to determine whether with a sufficient number of variants a linkage signal can be fully explained.
Method: We used comprehensive fine-mapping using a dense set of single nucleotide polymorphisms (SNPs) across the
entire quantitative trait locus (QTL) on human chromosome 7q36 linked to plasma triglyceride levels. Analyses included
measured genotype and combined linkage association analyses.
Results: Screening this linkage region, we found an over representation of nominally significant associations in five genes
(MLL3, DPP6, PAXIP1, HTR5A, INSIG1). However, no single genetic variant was sufficient to account for the linkage. On the
other hand, multiple variants capturing the variation in these five genes did account for the linkage at this locus.
Permutation analyses suggested that this reduction in LOD score was unlikely to have occurred by chance (p=0.008).
Discussion: With recent findings, it has become clear that most complex traits are influenced by a large number of genetic
variants each contributing only a small percentage to the overall phenotype. We found that with a sufficient number of
variants, the linkage can be fully explained. The results from this analysis suggest that perhaps the failure to identify causal
variants for linkage peaks may be due to multiple variants under the linkage peak with small individual effect, rather than a
single variant of large effect.
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Introduction
For decades, research efforts have tried to uncover the
underlying genetic basis of human susceptibility to a variety of
diseases. While our efforts untangling the basis of monogenic
disorders have been highly successful [1,2,3], advances in the
analysis of complex diseases such as diabetes and obesity, or
quantitative traits such as blood lipid levels have been slower [4,5].
The challenge for complex disease is that individual variants
contribute little to the overall genetic predisposition. Indeed,
recent findings from meta-analyses of genome-wide association
studies suggest that even these large-scale efforts so far can only
identify variants that together explain 5–15% of the genetic basis
of a trait [6,7,8,9]. This suggests that our current analysis
approaches and research efforts, including genome-wide associa-
tion studies, uncover novel genes contributing to disease
susceptibility, but still leave large numbers of genes and variants
to be uncovered that contribute to the genetic disease risk in the
general population [10].
Linkage studies have resulted in highly replicated findings and
helped identify quantitative trait loci (QTL) for many complex
traits; however identification of specific alleles accounting for the
linkage peak has remained elusive [11,12,13,14]. In most follow-
up analyses, the assumption has been that single variants (or a
limited number of variants) are responsible for the observed
linkage, and have significant individual effects. Based on the
limited success in finding causal variants, this may be a flawed
assumption. To date, numerous variants for a variety of complex
traits have been identified in linkage regions such as chromosome
20q for diabetes, but only a small fraction of the total linkage
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haplotypes [15]. Therefore, alternative approaches may be needed
to comprehensively investigate QTL, and these may require a
revised hypothesis about the causality of the observed linkage.
Thus, the purpose of this study was to determine whether with a
sufficient number of variants (rather than individual variants) a
linkage signal can be fully explained. To accomplish this goal, we
analyzed a quantitative trait locus (QTL) on human chromosome
7q36 linked to plasma triglyceride levels (LOD=3.7) [16], which
has been replicated in other studies [17,18,19,20]. To interrogate
this genomic interval of approximately 5 Mb, we used compre-
hensive fine-mapping using a dense set of single nucleotide
polymorphisms (SNPs) across the entire QTL interval. We then




The Metabolic Risk Complications of Obesity Genes (MRC-
OB) project was established in 1994 to identify the genetic
determinants of the metabolic syndrome and its metabolic
abnormalities [21]. Participant recruitment and individual phe-
notyping have been described in detail previously [16,21]. Briefly,
families with at least two obese siblings [body mass index
(BMI).30], the availability of one (preferably both) parent(s),
and one or more never obese sibling(s) (BMI,27) were recruited
from the TOPS (Take Off Pounds Sensibly, Inc.) membership in
10 Midwestern U.S. states. Health information of all participants
was obtained by a questionnaire, which included asthma, kidney
or liver disease, hypertension, heart disease, stroke, thyroid
disorders, diabetes, medications, menopausal status and hormonal
therapy, weight history, and smoking history. Individuals were
excluded from recruitment with the following conditions: preg-
nancy, type 1 diabetes, history of cancer, renal or hepatic disease,
severe coronary artery disease, substance abuse, corticosteroids or
thyroid dosages above replacement dose, history of weight loss of
more than 10% in the preceding 12 months, as well as individuals
receiving lipid-lowering medications. Phenotypic measurements
included height, weight, waist and hip circumferences, and fasting
plasma levels of glucose, insulin, total cholesterol, LDL-cholesterol,
HDL-cholesterol, and TG. A total of 2209 individuals distributed
over 507 families of Northern European descent qualified for the
above-mentioned criteria and thus formed the initial study
population, of which 1560 individuals from 261 families that
contributed most to the linkage were selected for further studies.
All protocols have been approved by the Institutional Review
Board of the Medical College of Wisconsin. Details on the cohort
used in this study are included in Table 1.
Initial Linkage Analysis
As previously reported (Sonnenberg et al), 2,209 individuals
from 507 families were ascertained for basic anthropomorphic
phenotypes, plasma lipid measures, and fasting glucose and insulin
levels. A genome-wide linkage scan of these families identified a
quantitative trait locus (QTL) on human chromosome 7q36 linked
to plasma triglyceride levels (LOD=3.7). The locus spans
approximately 5 Mb of genomic sequence, and contains 18
known genes.
Genotyping
We selected 1,048 tagSNPs spanning the entire 5 Mb region
using the tagger function of Haploview [22]. All SNPs were
genotyped on an Affymetrix MegAllele custom-designed 3K array
using molecular inversion probe technology, as described
previously [23,24].
Statistical Analysis
As triglyceride levels are continuously distributed, the data were
first examined for deviations from normality. Raw triglyceride
levels exhibited an increased number of high values, so the data
were natural log (ln) transformed. Data were re-examined and
observations exceeding 4 standard deviation units were removed
as outliers, as described previously [16]. All genetic analyses were
performed using the variance components framework and the
computer program SOLAR (Texas Biomedical Research Institute,
San Antonio, TX) [25].
Single SNP Analysis. For each SNP, we used the measured
genotype approach to test for association. Briefly, in this ap-
proach, the effects of the individual SNP genotypes will be
modeled by assigning genotypic values such that the homo-
zygotes will be assigned values of 1 and –1 and the heterozygotes
will be assigned 0, providing an additive model [26]. To account
for the phenotypic correlation between family members, we used
variance components analysis with the SNPs screened indivi-
dually as covariates. Other covariates for the single SNP models
included age, age by sex, sex, age squared, age squared by sex,
asthma, menopause status, birth control use, smoking status,
lipid lowering medications, and diabetes status. To test the
effects of individual SNPs, log likelihoods of models estimating
the effect of the SNP are compared to the log likelihoods of
models in which the SNP effect is constrained to zero. Under the
assumption that trait values in a family follow a multivariate
normal distribution, twice the difference in the log likelihoods of
these two models is asymptotically distributed as a chi-square
with one degree of freedom.
To determine whether any one SNP accounted for the linkage
peak, we then performed combined linkage association. In this
approach, we evaluated the evidence of linkage after accounting
for the SNP. If the SNP accounted for all of the linkage peak, the
LOD score would be expected to drop below 0.5 [27]. All
combined linkage association models included age, age by sex, sex,
age squared, age squared by sex, asthma, menopause status, birth
control use, smoking status, lipid lowering medications, and
diabetes status as covariates.
Multiple SNP Analysis. In order to assess whether clusters of
SNPs account for the observed linkage, we first examined the
location of all nominally associated SNPs from the initial analysis
to identify regions where these associated variants cluster.
To dissect the genetic effects of these cluster regions and to
assess the magnitude of effect on TG levels and the originally
observed linkage, we selected all SNPs in these cluster regions that
were used in the single SNP screen (n=324), including SNPs
regions that showed no evidence of single SNP association. To
minimize redundant information, SNPs were eliminated from
consideration if they exhibited substantial LD with other SNPs in
the analysis (r
2.0.7). For the sets of SNPs exhibiting substantial
LD, SNPs were eliminated on the basis of missing data, such that
SNPs with the lowest percentage of missing data were retained in
the analysis. Importantly, previous evidence of association was not
considered in the reduction of the SNP sets. The selected SNPs
were included in a model where each SNP was modeled
additively. Importantly, as our goal was not to determine the
significance of any specific SNP in the multi-SNP model, all SNPs
were forced to be included in the model but significance testing
was not performed. Other covariates included age, age by sex, sex,
age squared, age squared by sex, asthma, menopause status, birth
control use, smoking status, lipid lowering medications, and
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linkage analysis when the original QTL was identified.
To estimate the impact of incorporating these SNPs, we
performed a combined linkage association analysis. Briefly, in this
analysis weevaluated theevidenceof linkage when all selectedSNPs
were included in the analysis to a model where the effect of all of the
SNPs was constrained to zero. This permitted the comparison of
models with the same individuals. We then determined whether the
linkage peak was abolished (LOD,0.5) [27]. As the linkage peak
may be abolished because of over-parameterizing the model, we
then performed 500 permutations where the phenotypes were
randomly assigned to individuals. In each permutation, the LOD
score was estimated when all SNPs were included in the model. We
then counted the number of times that the LOD score was below
the 0.5 threshold. The empirical significance is the number of times
the LOD was below the threshold plus one divided by the number
of permutations performed.
Results
Single SNP Analysis. The results for the association analysis
of individual SNPs with plasma TG levels are illustrated in Figure 1.
Of the 1,048 SNPs, 109 showed association with plasma TG levels
at a nominal p-value of less than 0.05. Nine SNPs had p-values of
less than 0.001. Of all associated SNPs, 89 SNPs (82%) clustered in
regions ofhighLDaroundfivegenes(including10 kbupstream and
downstream of the coding region), MLL3, DPP6, PAXIP1,
HTR5A, and INSIG1, suggesting that these gene regions
contribute to the altered triglyceride profiles characteristic of the
metabolic syndrome in our cohort.
When examining the effect on the LOD score of each of the 109
SNPs which exhibited nominal p-values we found that no one SNP
explained the linkage peak (LOD score dropped below 0.05).
Indeed, the median value for the proportion LOD decline was
0.03 (interquartile range: 0.002–0.05). Further, only 15 SNPs
exhibited LOD drops greater than 0.10. Taken together these data
suggest that any one SNP in this region is insufficient to explain
the linkage peak.
Multiple SNP Analysis. For further analysis, we selected
all SNPs (n=324) surrounding these five genes identified in the
single SNP screen. Of these variants, 160 SNPs had low
pairwise linkage disequilibrium measures (r
2,0.7). When all
160 SNPs were included in the analysis model, 684 individuals
had complete genotype information for all SNPs and thus
entered the analysis. The covariates (including the SNPs)
explained 36% of the variance in triglycerides and there was no
evidence of any additional genetic effect for the locus on 7q36
(heritability=0, LOD=0.05 at the QTL). When restricting the
analysis to the same 684 individuals but not including the SNPs
as covariates, the remaining covariates explained only 5% of
the variation in triglycerides and there was strong evidence of a
genetic effect (heritability=0.2660.08, LOD=3.1 at the
QTL).
Of the 500 permutations, only 3 achieved LOD scores less than
0.5, resulting in an empirical p-value of 0.008 for the LOD score
to fall below 0.5. Further, in the permutations, the LOD score
never reached the LOD score obtained with the real data,
supporting the significance of these findings.
These data clearly indicate that the observed linkage effect is
not due to a single variant. To ensure that a single gene was not
driving the analysis, we then split these 160 SNPs into the five
genes. Results from the by gene analyses are presented in
Table 2. Briefly, the number of SNPs per gene ranged from 5
(PAXIP1) to 111 (DPP6). The proportion of the LOD score
decline ranged from 1.15% (PAXIP1) to 81.3% (DPP6).
However, the proportion of decline was associated with the
number of SNPs included (p=0.002). As there are a large
number of SNPs included from DPP6, we recognize that the
proportion of variation explained by this gene is elevated likely
due to long range LD with the other candidate genes in this
region. Importantly, even including multiple variants from a
single gene is not sufficient to obtain evidence for the accounting
of the LOD score. Only the combination of multiple SNPs
across multiple genes is sufficient to fully explain the observed
linkage signal.
Table 1. Descriptive Statistics of the Take Off Pounds Sensibly (TOPS) Cohort and the subsets used for following up linkage
analysis.
Trait Original Linkage Cohort Follow Up Cohort – linking to 7q36
Individuals with Complete
Genotyping on 120 SNPs
N 2007 1235 684
# Families 401 258 225
Family Size (mean (range)) 5.0 (2–29) 4.8 (2–27) 3.0 (1–10)
Age (years) 48.12615.10 47.92614.80 47.47614.89
Triglycerides 128.73681.19 129.57683.70 130.04680.45
Ln triglycerides 4.7160.53 4.7160.54 4.7260.54
Sex (% male) 23.5 23.8 21.5
Asthma (% Y) 8.5 9.5 8.8
Menopausal (% Post) 40.0 40.5 42.8
Estrogen Use (% Y) 17.7 18.5 19.7
Ever Smoke (% Y) 22.0 16.0 17.0
Cholesterol/LDL medications 3.5 2.9 2.6
Type 2 Diabetes (% Y) 15.9 16.9 19.4
Diabetes Medications (% Y) 5.2 5.7 6.4
doi:10.1371/journal.pone.0034614.t001
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With recent findings, it has become clear that most complex
traits are influenced by a large number of genetic variants each
contributing only a small percentage to the overall phenotype.
Thus the question remains for complex traits whether a linkage
peak can be explained in entirety with a sufficient number of
variants. Using a family based cohort which exhibited linkage for
plasma triglycerides to human chromosome 7q36, we have
demonstrated that a single genetic variant is insufficient to account
for the linkage peak. Further, we demonstrated that using multiple
variants capturing the variation in five genes (MLL3, DPP6,
PAXIP1, HTR5A, INSIG1). this linkage peak can be explained
completely.
In this study, we coupled information from linkage and
association to clarify the genetic basis of variation in plasma
triglyceride concentrations. A major benefit of using this combined
approach is that these methods provide independent information
[28] and thus improve power [29]. Therefore, regions where there
is already prior evidence of linkage are more likely to contain
causal variants than regions which do not. In addition, the false-
positive results from linkage can be vetted by requiring that SNPs
are not only associated but also explain at least part of the linkage
peak because of the independence of the two tests. Indeed, this
approach has been used in simulated data to demonstrate its
power to detect the functional variants [30,31].
Using a comprehensive set of 1,048 tagSNPs identified from the
publicly available data of the International HapMap Consortium
[32], we examined the effect of both individual SNPs and clusters
of variants on the observed linkage. Of the 1,048 SNPs, 109 SNPs
showed nominal association with plasma TG (p,0.05). Of these
SNPs, 89 (82%) clustered around five genes, MLL3, DPP6,
PAXIP1, HTR5A, and INSIG1, suggesting that these genes
significantly contribute to the altered lipid profiles. Several of these
genes are biologically plausible candidates for lipid related
phenotypes. INSIG1 has been demonstrated to regulate expres-
sion of sterol regulatory element-binding protein target genes and
are required for lipogenesis [33]. While MLL3 and PAXIP1 have
not been implicated in lipid metabolism, they play a role in
PPARc dependent adipogenesis [34,35] and activation of PPARc
improves lipid homeostasis [36]. Lastly, HTR5A is involved in
central metabolic balancing [37], and many of the serotonin
receptor genes have been associated with obesity related traits
[38]. DPP6 has not been implicated in lipid metabolism rather
seems to be important in neuronal signaling [39,40].
While these genes are plausible, no single SNP explained a
significant fraction of the linkage, suggesting that multiple variants
of small individual effect account for the QTL. While the
identification of causal variants following an initial linkage study
has worked well for Mendelian disorders, the failure to identify a
single variant that accounts for a linkage peak for a complex trait
consistent with previous fine-mapping studies [11,12,13,14,41]. A
reason for such a failure may be allelic heterogeneity within the
locus.
On the other hand, accounting for many variants irrespective of
the level of association can account for the linkage peak. One
hundred sixty variants (15.3% of the 1048 SNPs tested) randomly
selected from these five genes completely account for the linkage
on chromosome 7q36. However, as the purpose of this paper was
to determine if capturing the variation present in these five genes
would be sufficient to explain the linkage, we did not seek to
Figure 1. Plot of single SNP association across the QTL interval on human chromosome 7q36. The positions for each SNP are listed on
the x-axis, and are based on the genome assembly hg19. SNPs included in the targeted multi-SNP analysis (160 SNPs) are highlighted in back. The
bars on the top of the diagram highlight the position of all coding sequences in the interval, the five genes of interest are labeled.
doi:10.1371/journal.pone.0034614.g001
Table 2. Impact of Adjusting for SNPS by Candidate Gene.
Gene Number of SNPsBase LOD Adjusted LOD % Decline
MLL3 8 9.14 8.88 2.8
PAXIP1 5 7.96 7.87 1.15
INSIG1 16 6.36 5.23 17.7
HTR5A 20 7.76 5.89 24.1
DPP6 111 5.78 1.08 81.3
doi:10.1371/journal.pone.0034614.t002
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linkage or the specific variants. Given the linkage disequilibrium in
this region, it is plausible that the causal variants are not in the 160
variants selected. Future studies will need to examine this locus in
more detail to identify the specific variants responsible for the
linkage.
These results suggest that a single genetic variant is not likely to
be the cause of a linkage signal for a complex trait. Indeed, even in
the simple Mendelian inherited diseases such as cystic fibrosis [42]
and Holt Oram syndrome [43,44] exhibit multiple causal variants
at a locus. This scenario creates a challenge for gene discovery
with association because association is simply looking for whether
the phenotype differs by the variant. If multiple variants can all
result in the same phenotype, then the power to detect association
is small. However, in linkage analysis the assumption is that the
region segregates with disease, thus if there are multiple causal
variants segregating, evidence of linkage will be present but not
evidence of association. Previous studies have failed to find strong
relationships between linkage peaks and association peaks [10].
Others have speculated that linkage peaks results from multiple
variants [41,45,46,47]; our analysis supports this. Thus, future
studies will need to utilize methods designed to assess the impact of
multiple variants on a linkage peak such as the methods proposed
by Chen and colleagues [41].
In this study, we demonstrate that a single SNP or gene is
insufficient to explain the linkage of serum triglycerides on 7q36.
Indeed, while we observe a cluster of associated SNPs in five genes,
any single SNP or gene fails to completely account for the linkage
peak. On the other hand, when we select SNPs across all five
genes, evidence of linkage disappears, suggesting that multiple
variants in these genes significantly alter plasma triglyceride levels.
Our findings suggest that the failure to identify causal variants for
linkage peaks may be due to multiple variants under the linkage
peak with small individual effect, rather than a single variant of
large effect.
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